Table Of Content

an international journal se ELSEVIER Master Author and Key word Indexes, Volumes 229-248, 1993 (EJP Molecular Pharmacology Section, Volumes 244-247, and EJP Environmental Toxicology and Pharmacology Section, Volume 248, incorporated) EUROPEAN JOURNAL OF PHARMACOLOGY INDEXES 1993 european journal of pharmacology Author and Key word Indexes, 1993 Volumes 229-248 (EJP Molecular Pharmacology Section, Volumes 244-247, and EJP Environmental Toxicology and Pharmacology Section, Volume 248, incorporated) ELSEVIER AMSTERDAM — LONDON — NEW YORK — TOKYO © 1994 Elsevier Science B.V. All rights reserved No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the publisher, Elsevier Science B.V., Copyright and Permissions Department, P.O. Box 521, 1000 AM Amsterdam, The Netherlands. No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of the rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. Special regulations for authors. Upon acceptance of an article by the journal, the author(s) will be asked to transfer copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information. Special regulations for readers in the U.S.A. This journal has been registered with the Copyright Clearance Center, Inc. Consent is given for copying of articles for personal or internal use, or for the personal use of specific clients. This consent is given on the condition that the copier pays through the Center the per-copy fee stated in the code on the first page of each article for copying beyond that permitted by Sections 107 or 108 of the U.S. Copyright Law. The appropriate fee should be forwarded with a copy of the first page of the article to the Copyright Clearance Center, Inc., 27 Congress Street, Salem, MA 01970, U.S.A. If no code appears in an article, the author has not given broad consent to copy and permission to copy must be obtained directly from the author. The fee indicated on the first page of an article in this issue will apply retroactively to all articles published in the journal, regardless of the year of publication. This consent does not extend to other kinds of copying, such as for general distribution, resale, advertising and promotion purposes, or for creating new collective works. Special written permission must be obtained from the publisher for such copying. This journal is in the ADONIS Service, whereby copies of individual articles can be printed out from CD-ROM on request. An explanatory leaflet can be obtained by writing to ADONIS B.V., P.O. Box 839, 1000 AV Amsterdam, The Netherlands. This journal is printed on acid-free paper. US mailing notice - European Journal of Pharmacology (ISSN 0014-2999) is published 3 times/month by Elsevier Science B.V. (Molenwerf |, Postbus 211, 1.v¥0 AE Amsterdam, The Netherlands). Annual subscription price in the USA is US$ 4222.00 (valid in North, Central and South America only) including air speed delivery. Second class postage rate is paid at Jamaica, NY 11431. USA POSTMASTERS: Send address changes to European Journal of Pharmacology, Publications Expediting, Inc., 200 Meacham Avenue, Elmont, NY 11003. Airfreight and mailing in the USA by Publications Expediting. Printed in The Netherlands ELSEVIER Master author index to volumes 229-248 (1993) Abacioglu, N., see Cakici, i. (236) 97 Akiba, T., see Hikasa, Y. (229) 241 Abbenante, J., see Kerr, D.1.B. (236) 239 Aktories, K., see Just, I. (246) 293 Abe, Y., see Tamaki, T. (236) 15 Al-Tikriti, M.S., see Laruelle, M. (230) 119 Abi-Dargham, A., see Laruelle, M. (230) 119 Al-Zubaidy, Z., see Chapman, A.G. (231) 301 Abiko, Y., see Hoque, A.N.E. (236) 269 Ala-Uotila, S., see Marjamaki, A. (246) 219 Abiru, T., Watanabe, Y., Kamata, K. and Kasuya, Y. Alabadi, J.A., see Alborch, E. (229) 83 Simultaneous measurement of vasodilation and changes in cyclic Alanko, J., see Saareks, V. (248) 345 nucleotides in the perfused mesenteric arterial bed of the rat Alary, C., see Gué, M. (233) 193 (242) 15 Alborch, E., Salom, J.B., Perales, A.J., Torregrosa, G., Miranda, FJ., Abrahams, T.P., Taveira DaSilva, A.M., Hamosh, P., McManigle, Alabadi, J.A. and Jover, T. J.E. and Gillis, R.A. Comparison of the anticonstrictor action of dihydropyridines Cardiorespiratory effects produced by blockade of excitatory (nimodipine and nicardipine) and Mg** in isolated human cere- amino acid receptors in cats (238) 223 bral arteries (229) 83 Abrahams, Z., Chang, $.D. and Sutter, M.C. Alcalde, A.1., see Sorribas, V. (248) 137 Stimulant effect of human gamma globulin on smooth muscle Alhaider, A.A., see Mustafa, A.A. (237) 147 preparations (238) 435 Allard, B. and Lazdunski, M. Abram, T.S., see Gardiner, P.J. (238) 19 Pharmacological properties of ATP-sensitive K* channels in Aceto, M.D., Scates, $.M., Ji, Z. and Bowman, E.R. mammalian skeletal muscle cells (236) 419 Nicotine’s opioid and anti-opioid interactions: proposed role in Allen, R.D., see Ong, J. (233) 169 smoking behavior (248) 333 Allerup, P., see Glenthgj, B. (236) 401 Acquas, E., Meloni, M. and Di Chiara, G. Allgeier, A., see Van Sande, J. (247) 177 Blockade of 5-opioid receptors in the nucleus accumbens pre- Allgeier, H., see Benke, D. (246) 179 vents ethanol-induced stimulation of dopamine release (230) 239 Allix, M., see Wahl, F. (230) 209 Adachi, N., see Oishi, R. (237) 155 Alm, P., see Panagiotidis, G. (229) 277 Adami, M., see Trampus, M. (235) 83 Almotrefi, A.A., see Dzimiri, N. (242) 113 Adams, M.E., see Burke, S.P. (238) 383 Alsip, N.L. and Harris, P.D. Adeyemo, O.M., Youdim, M.B.H., Markey, S.P., Markey, C.J. and Serotonin-induced dilation of smali arterioles is not mediated via Pollard, H.B. endothelium-derived relaxing factor in skeletal muscle (229) 117 L-Deprenyl confers specific protection against MPTP-induced Altavilla, D., see Squadrito, F. (230) 125 Parkinson’s disease-like movement disorder in the goldfish (240) Altavilla, D., see Squadrito, F. (237) 223 185 Altmann, L., see Guilarte, T.R. (248) 273 Adler, L., see Huether, G. (238) 249 Altura, B.M., Zhang, A., Cheng, T.P.-O. and Altura, B.T. Adolfo Garcia-Sainz, J., see Medina-Martinez, O. (244) 145 Cocaine induces rapid loss of intracellular free Mg?* in cerebral Advenier, C., see Dumas, M. (239) 141 vascular smooth muscle cells (246) 299 Advenier, C., see Martin, C.A.E. (239) 119 Altura, B.M., see Zhang, A. (248) 229 Advenier, C., see Martin, C.A.E. (243) 309 Altura, B.T., see Altura, B.M. (246) 299 Agnati, L.F., see Martire, M. (230) 231 Altura, B.T., see Zhang, A. (248) 229 Agrotis, A., Little, P.J., Saltis, J. and Bobik, A. Alvarado, F., see Sorribas, V. (248) 137 Dihydropyridine Ca** channel antagonists inhibit the salvage Alvarez Sanz, M.C., see Levy, A.D. (241) 275 pathway for DNA synthesis in human vascular smooth muscle Ambar, |. and Sokolovsky, M. cells (244) 269 Endothelin receptors stimulate both phospholipase C and phos- Ahima, R.S., see Osei, S.Y. (234) 35 pholipase D activities in different cell lines (245) 31 Ahlborg, U.G., see Hemming, H. (248) 163 Amenta, F., see Ferrante, F. (240) 229 Ahlenius, S., see Salmi, P. (236) 395 Amenta, F., see Ferreira-de-Almeida, J.A. (234) 209 Ahrén, B., see Gregersen, S. (232) 35 Amerini, S., see Lodovici, M. (243) 255 Ahrén, B., see Skoglund, G. (236) 69 Amico-Roxas, M., see Clementi, G. (238) 101 Aishita, H., see Nakagawa, N. (235) 211 Amore, C., see lacoviello, L. (229) 39 Aizenman, E., see Reynolds, 1.J. (244) 175 Amorim, C.Z., Cordeiro, R.S.B. and Vargaftig, B.B. Akaike, A., Tamura, Y., Sato, Y. and Yokota, T. Involvement of platelet-activating factor in death following ana- Protective effects of a vitamin B,, analog, methylcobalamin, phylactic shock in boosted and in unboosted mice (235) 17 against glutamate cytotoxicity in cultured cortical neurons (241) | Amorim, C.Z., Cordeiro, R.S.B. and Vargaftig, B.B. Akera, T., see Temma, K. (234) 173 Interference of PCA 4248, a novel PAF receptor antagonist, with Akeson, A.L., see French, J.F. (233) 109 antigen-induced paw edema in mice (236) 301 Aki, Y., see Tamaki, T. (236) 15 Amrani, Y., see Trifilieff, A. (239) 227 Anderson, C.M., see Morgan, D.W. (235) 45 Asin, K.E. and Wirtshafter, D. Andrews, N. and File, S.E. Effects of repeated dopamine D, receptor stimulation on rota- Handling history of rats modifies behavioural effects of drugs in tion and c-fos expression (235) 167 the elevated plus-maze test of anxiety (235) 109 Assié, M.-B., Sleight, AJ. and Koek, W. Andrews, N., see File, S.E. (237) 127 Biphasic displacement of [*H]YM-09151-2 binding in the rat Andrews, N., see Rattray, M. (245) 193 brain by thioridazine, risperidone and clozapine, but not by other Anelli, M., see Caccia, S. (233) 71 antipsychotics (237) 183 Angel, I., Grosset, A., Perrault, G., Schoemaker, H. and Langer, S.Z. Atkinson, J., see Gohar, M. (229) 69 In vivo pharmacological profile of SL 84.0418, a new selective, Ator, N.A., Grant, K.A., Purdy, R.H., Paul, $.M. and Griffiths, R.R. peripherally active a,-adrenoceptor antagonist (234) 137 Drug discrimination analysis of endogenous neuroactive steroids Angel, I., Schoemaker, H., Prouteau, M., Garreau, M. and Langer, in rats (241) 237 S.Z. Attali, B., see Nah, S.-Y. (244) 67 Litoxetine: a selective 5-HT uptake inhibitor with concomitant Attila, M., see Salvadori, S. (230) 357 5-HT, receptor antagonist and antiemetic properties (232) 139 Audia, J.E., see Johnson, M.P. (239) 111 Angst, C., see Benke, D. (246) 179 Aulakh, C.S., Hill, J.L. and Murphy, D.L. Angulo, J.A., Watanabe, Y., Cadet, J.. Ledoux, M. and McEwen, Attenuation of hypercortisolemia in fawn-hooded rats by antide- B.S. pressant drugs (240) 85 Upregulation of forebrain proenkephalin mRNA subsequent to Aulakh, C.S., see Hulihan-Giblin, B.A. (239) 99 NMDA receptor blockade (244) 317 Aurell, C.-J., see Vilhardt, H. (232) 223 Annies, R., see Léscher, W. (242) 263 Awere, S., see Moore, N.A. (237) 1 Annunziato, L., see Canzoniero, L.M.T. (245) 97 Azmitia, E.C., see Gu, X.F. (235) 51 Anthony, T.L., see Knoper, S.R. (232) 65 Antunes, E., see Santana, A.C. (231) 237 Aoyagi, T., see Majima, M. (232) 181 Bachetti, T., see Spampinato, S. (244) 139 Arakawa, H., Kawikova, I., L6fdahl, C.-G. and Létvall, J. Bachy, A., Héaulme, M., Giudice, A., Michaud, J.-C., Lefevre, 1.A., Bradykinin-induced airway responses in guinea pig: effects of Souilhac, J., Manara, L., Emerit, M.B., Gozlan, H., Hamon, M., inhibition of cyclooxygenase and thromboxane synthetase (229) Keane, P.E., Soubrié, P. and Le Fur, G. 131 SR 57227A: a potent and selective agonist at central and periph- Araki, T., see Kanai, Y. (248) 191 eral 5-HT, receptors in vitro and in vivo (237) 299 Aranyi, P., see Horvath, E.J. (236) 151 Badgery-Parker, T., see Burcher, E. (233) 201 Arbilla, S., see Faure-Halley, C. (246) 283 Badia, A., see Vivas, N.M. (245) 9 Archer, S., see Jiang, Q. (230) 129 Baeyens, J.M., see Ocafia, M. (230) 203 Archer, S., see Jiang, Q. (240) 201 Baeyens, J.M., see Ocafia, M. (239) 253 Ardaillou, R., see Chansel, D. (247) 193 Bagdy, G., Kalogeras, K.T. and Szemeredi, K. Arias-Montano, J.-A. and Young, J.M. Effect of 5-HT,- and 5-HT, receptor stimulation on excessive Locus of action of Ni?* on histamine-induced inositol phosphate grooming, penile erection and plasma oxytocin concentrations formation in brain slices and in HeLa cells (245) 221 (229) 9 Arias-Montafo, J.-A. and Young, J.M. Bagetta, G., Massoud, R., Rodind, P., Federici, G. and Nisticd, G. Characteristics of histamine H, receptors on HeLa cells (245) 291 Systemic administration of lithium chloride and tacrine increases Arimura, A., Asanuma, F., Yagi, H., Kurosawa, A. and Harada, M. nitric oxide synthase activity in the hippocampus of rats (237) 61 Involvement of thromboxane A, in bronchial hyperresponsive- Bagrov, A.Y., Roukoyatkina, N.I., Fedorova, O.V., Pinaev, A.G. and ness but not lung inflammation induced by bacterial lipopolysac- Ukhanova, M.V. charide in guinea pigs (231) 13 Digitalis-like and vasoconstrictor effects of endogenous digoxin- Armario, A., see Marti, J. (236) 295 like factor(s) from the venom of Bufo marinus toad (234) 165 Arnal, J.-F., El Amrani, A.-I. and Michel, J.-B. Bai, X., see Walker, J.M. (231) 61 Atrial natriuretic factor influences in vivo plasma, lung and aortic Bai, X., see Walker, J.M. (236) 495 wall cGMP concentrations differently (237) 265 Bailey, M.A. and Karbon, E.W. Arnold, I.R., Mistry, R. and Barnett, D.B. Haloperidol treatment differentially regulates [SHJDTG and Subtype selective regulation of coupling of rat cardiac B-adreno- [SHK +)-3-PPP labeled o binding sites (240) 243 ceptors to adenylate cyclase (245) 285 Baker, J., see Lummis, S.C.R. (243) 7 Arora, R.C., see Gulati, A. (231) 151 Bakhle, Y.S., see Santana, A.C. (231) 237 Arruebo, M.P., see Sorribas, V. (248) 137 Bakker, J.M., see Heijna, M.H. (229) 197 Artalejo, A.R., see Montiel, C. (230) 77 Bakthavachalam, V., see Baldessarini, R.J. (239) 269 Artalejo, C.R., see Priego, J. (243) 25 Balasubramaniam, G., Lee, H.S. and Mah, S.C. Artigas, F., see Bel, N. (229) 101 Antihypertensive effect of chronic i.v. administration of 5-carbox- Artigas, F., see Bel, N. (232) 326 amidotryptamine in spontaneously hypertensive rats (237) 207 Asahina, T., see Tanaka, Y. (244) 105 Balboni, G., see Romualdi, P. (229) 149 Asai, Y., see Umemura, K. (239) 17 Baldessarini, R.J., Kula, N.S., McGrath, C.R., Bakthavachalam, V., Asano, M., Matsuda, T., Hayakawa, M., Itu, K.M. and Ito, K. Kebabian, J.W. and Neumeyer, J.L. Increased resting Ca** maintains the myogenic tone and acti- Isomeric selectivity at dopamine D, receptors (239) 269 vates K* channels in arteries from young spontaneously hyper- Balduini, W., Cimino, M., Rend, F., Marini, P., Princivalle, A. and tensive rats (247) 295 Cattabeni, F. Asanuma, F., see Arimura, A. (231) 13 Effects of postnatal or adult chronic acetylcholinesterase inhibi- Ashford, M.L.J., see Lee, K. (247) 347 tion on muscarinic receptors, phosphoinositide turnover and m, Ashida, S.-i., see Watabe, S. (238) 303 mRNA expression (248) 281 Ashino, H., see Oikawa, T. (241) 221 Baldwin, R.M., see Laruelle, M. (230) 119 Ball, S.G., see Hall, A.S. (247) 249 Baugh, L.E., see Kudlacz, E.M. (241) 17 Balloy, V., see Renesto, P. (248) 151 Bax, W.A., Bos, E. and Saxena, P.R. Balmforth, A.J., see Hall, A.S. (247) 249 Heterogeneity of endothelin/sarafotoxin receptors mediating Balster, R.L., see Gold, L.H. (230) 285 contraction of the human isolated saphenous vein (239) 267 Bangalore, R., see Hawthorn, M.H. (229) 143 Bax, W.A., Renzenbrink, G.J., Van Heuven-Nolsen, D., Thijssen, Baptista, T., Weiss, S.R.B. and Post, R.M. E.J.M., Bos, E. and Saxena, P.R. Carbamazepine attenuates cocaine-induced increases in dopa- 5-HT receptors mediating contractions of the isolated human mine in the nucleus accumbens: an in vivo dialysis study (236) 39 coronary artery (239) 203 Barber, A. Bax, W.A., see Schoemaker, R.G. (230) 103 u- and «-opioid receptor agonists produce peripheral inhibition Bazan, E., Campbell, A.K. and Rapoport, R.M. of neurogenic plasma extravasation in rat skin (236) 113 Effects of protein kinase C activation on norepinephrine-induced Barber, P.C., see Barnes, J.M. (230) 251 phosphatidylinositide hydrolysis in intact rat aorta (245) 173 Barclay, P.L., see Scott, J.M. (242) 91 Bazzoni, G., see Cerri, M.A. (232) 291 Bardgett, M.E., Wrona, C.T., Newcomer, J.W. and Csernansky, J.G. Beal, M.F., see Nozaki, K. (232) 295 Subcortical excitatory amino acid levels after acute and sub- Beani, L., see Tanganelli, S$. (230) 159 chronic administration of typical and atypical neuroleptics (230) Beaudet, A., see Pasquini, F. (243) 39 245 Beaujouan, J.-C., see Petitet, F. (247) 185 Barnard, E.A., see Fujita, R. (240) 213 Beer, M.S. and Middlemiss, D.N. Barnes, J.M., Steward, L.J., Barber, P.C. and Barnes, N.M. Serotonin-5-O-carboxymethyl-glycyl{!*>I}tyrosinamide labels the Identification and characterisation of angiotensin II receptor 5-HT jpg receptor subtype in human cortex (242) 195 subtypes in human brain (230) 251 Beer, M.S., Stanton, J.A., Hawkins, L.M. and Middlemiss, D.N. Barnes, N.M., see Barnes, J.M. (230) 251 5-Carboxamidotryptamine-insensitive 5-HT,-like receptors are Barnes, N.M., see Steward, L.J. (242) 137 concentrated in guinea pig but not rat, claustrum (236) 167 Barnes, N.M., see Steward, L.J. (243) 13 Bel, N. and Artigas, F. Barnes, P.J., see Belvisi, M.G. (231) 97 Fluvoxamine preferentially increases extracellular 5-hydroxy- Barnes, P.J., see Kato, M. (232) 7 tryptamine in the raphe nuclei: an in vivo microdialysis study Barnes, P.J., see Lei, Y.-H. (239) 257 (229) 101 Barnes, P.J., see Nishikawa, M. (247) 131 Bel, N. and Artigas, F. Barnes, P.J., see Rabe, K.F. (231) 305 Fluvoxamine preferentially increases extracellular 5-hydroxy- Barnes, P.J., see Sakamoto, T. (231) 31 tryptamine in the raphe nuclei: an in vivo microdialysis study. Barnett, D.B., see Arnold, I.R. (245) 285 European Journal of Pharmacology, 229 (1992) 101-103 (232) 326 Barone, D., see Bianchi, G. (238) 327 Belcourt, A., see Bennai, F. (246) 45 Barr, G.A. and Wang, S. Bélichard, P., see Pruneau, D. (231) 215 Behavioral effects of chronic cocaine treatment in the week-old Bélichard, P., see Pruneau, D. (239) 63 rat pup (233) 143 Bellan, J.A., Longenecker, L.L., Kadowitz, PJ. and McNamara, D.B. Barrett, J.E., see Gleeson, S. (229) 109 Selective and complete blockade of acetylcholine-induced relax- Barry, D.1., see Glenthgj, B. (236) 401 ation in rabbit aortic rings by N“-nitro-L-arginine but not by Bartfai, T., see Gregersen, S. (232) 35 glybenclamide (234) 273 Bartfai, T., see Zini, S. (245) 1 Belogi, L., see Tubaro, E. (248) 175 Barth, T., see Vilhardt, H. (232) 223 Beltran-Nufiez, A., see Cerri, M.A. (232) 291 Barthelmebs, M., see Michel, B. (242) 237 Belvisi, M.G., Miura, M., Stretton, D. and Barnes, P_J. Bartrons, R., see Planas, M.E. (237) 251 Endogenous vasoactive intestinal peptide and nitric oxide modu- Bashir, Z.1., Jane, D.E., Sunter, D.C., Watkins, J.C. and Collingridge, late cholinergic neurotransmission in guinea-pig trachea (231) 97 G.L. Bemelmans, M., see Huijberts, M. (240) 207 Metabotropic glutamate receptors contribute to the induction of Bemis, K.G., see Shannon, H.E. (232) 47 long-term depression in the CAI region of the hippocampus (239) Ben-Ari, Y., see Zini, S. (245) 1 265 Bendotti, C., see Parolaro, D. (244) 211 Baskys, A., Wang, S., Remington, G. and Wojtowicz, J.M. Benitah, J.-P., see Le Grand, B. (229) 91 Haloperidol and loxapine but not clozapine increase synaptic Benke, D., Marti, T., Heckendorn, R., Rehm, H., Kiinzi, R., All- responses in the hippocampus (235) 305 geier, H., Angst, C. and Mohler, H. Bassi, L., see Cerri, M.A. (232) 291 Photoaffinity labeling of the NMDA receptor (246) 179 Bast, A., see Smit, M.J. (247) 223 Bennai, F., Greney, H., Bricca, G., Belcourt, A., Bousquet, P. and Bast, A., see Ter Laak, A.M. (232) 199 Dontenwill, M. Batra, S., see Kostrzewska, A. (233) 127 Polyclonal anti-idazoxan antibodies: characterization and purifi- Battistini, B., see Filep, J.G. (239) 231 cation (246) 45 Battistini, B., see Filep, J.G. (240) 315 Bennardini, F., see Lodovici, M. (243) 255 Battula, N., see Salonpaa, P. (248) 95 Bensoussan, M., Mitchell, T., Reilly, T., Timmermans, P.B.M.W.M., Baudrie, V., De Vry, J., Broqua, P., Schmidt, B., Chaouloff, F. and Verroust, P.J. and Ronco, P.M. Glaser, T. Immunological reactivity of angiotensin II receptor antagonists: Subchronic treatment with anxiolytic doses of the 5-HT,, recep- possible implications for receptor binding sites (247) 169 tor agonist ipsapirone does not affect 5-HT, receptor sensitivity Benthem, L., Scheurink, AJ.W., Van der Leest, J., Leuvenink, H.., in the rat (231) 395 Zijlstra, W.G. and Steffens, A.B. Baudrie, V., see Chaouloff, F. (231) 77 Effects of long-term d-fenfluramine treatment on energy Baudry, M., see Marvizén, J.-C. (244) 103 metabolism in rats (232) 279 Benvenga, M.J. and Leander, J.D. Billman, G.E. Antidepressant-like effect of LY228729 as measured in the ro- Ro 40-5967, a novel calcium channel antagonist, protects against dent forced swim paradigm (239) 249 ventricular fibrillation (229) 179 Beretta, A., see Sandrini, G. (243) 99 Binet, P., see Scamps, F. (244) 119 Bereznai, B., see Deckert, J. (238) 131 Bird, J.E. and Waldron, T.L. Berg, M., see Johansson-Wallsten, C.E. (243) 149 Incomplete inhibition of endothelin-1 pressor effects by an en- Bergeron, R., Debonnel, G. and De Montigny, C. dothelin ET, receptor antagonist (240) 295 Modification of the N-methyl-D-aspartate response by antide- Bisaga, A., Krzascik, P., Jankowska, E., Palejko, W., Kostowski, W. pressant o receptor ligands (240) 319 and Danysz, W. Bergman, A., see Hemming, H. (248) 163 Effect of glutamate receptor antagonists on N-methyl-D-aspar- Berkenboom, G., see Unger, P. (248) 145 tate- and (S)-a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Berkenbosch, A., Rupreht, J.. DeGoede, J., Olievier, C.N. and acid-induced convulsant effects in mice and rats (242) 213 Wolsink, J.G. Bischoff, S., see Bruinink, A. (245) 157 Effects of eseroline on the ventilatory response to CO, (232) 21 Bitar, K.G., see Cheng, D.Y. (243) 79 Berkenkopf, J.W., see Grimes, D. (236) 217 Biton, C., see Randle, J.C.R. (247) 257 Berkenkopf, J.W., see Heaslip, R.J. (234) 247 Bittiger, H., see Olpe, H.-R. (233) 179 Bernad, N., see Lignon, M.-F. (245) 241 Blackman, A., see Moore, N.A. (237) 1 Bernard, J.-F., see Huang, G.-F. (230) 279 Blankesteijn, W.M., Siero, H.L.M., Rodrigues de Miranda, J.F., Bernard, J.-F., see Huang, G.-F. (236) 449 Van Megen, Y.J.B. and Russel, F.G.M. Bernard, M., see Pontoire, C. (247) 111 Characterization of muscarinic receptors in rat kidney (244) 21 Bernasconi. S., see Cerri, M.A. (232) 291 Bloemers, S.M., see Smit, M.J. (247) 223 Bernier, S., see Poitras, M. (244) 203 Blokland, A., Bothmer, J., Honig, W. and Jolles, J. Berning, B., see Rupprecht, R. (247) 145 Behavioural and biochemical effects of acute central metabolic Bertrand, C., see Huber, O. (239) 103 inhibition: effects of acetyl-l-carnitine (235) 275 Bertrand, C., see Yamawaki, I. (243) 1 Bloom, J.W., see Witt-Enderby, P.A. (241) 121 Bertrand, G., Gross, R., Puech, R., Loubatiéres-Mariani, M.-M. and Bloss, J.L., see Hammond, D.L. (231) 281 Bockaert, J. Bobik, A., see Agrotis, A. (244) 269 Glutamate stimulates glucagon secretion via an excitatory amino Bockaert, J., see Bertrand, G. (237) 45 acid receptor of the AMPA subtype in rat pancreas (237) 45 Bockaert, J., see Didier, M. (244) 57 Bervoets, K., see Millan, M.J. (230) 99 Boden, P.R., see Norris, S.K. (234) 223 Berzetei-Gurske, I.P., see Webster, J.L. (231) 251 Boev, K.K., see Gagov, H.S. (243) 19 Besson, J.-M., see Huang, G.-F. (230) 279 Boeynaems, J.-M., Heilporn, S., Broeders, F. and Braekman, J.-C. Besson, J.-M., see Huang, G.-F. (236) 449 Enhancement of the endothelial preduction of prostacyclin by Bethea, C.L., see Levy, A.D. (241) 275 substituted derivatives of BAPTA-AM (233) 13 Betito, K., Diorio, J. and Boksa, P. Boeynaems, J.-M., see Pirotton, S. (241) 55 Brief cortisol exposure elevates adrenal phenylethanolamine N- Bojé, L., Lefebvre, R.A., Nellgard, P. and Cassuto, J. methyltransferase after a necessary lag period (238) 273 Involvement of vasoactive intestinal polypeptide in gastric reflex Beubler, E., Schirgi-Degen, A. and Gamse, R. relaxation (236) 443 Inhibition of 5-hydroxytryptamine- and enterotoxin-induced fluid Boksa, P., see Betito, K. (238) 273 secretion by 5-HT receptor antagonists in the rat jejunum (248) Bolanos-Jiménez, F., Manhaes de Castro, R. and Fillion, G. 157 Antagonism by citalopram and tianeptine of presynaptic 5-HT), Bhargava, H.N., see Veeranna, (235) 23 heteroreceptors inhibiting acetylcholine release (242) 1 Bhatia, A.J., see Zorad, S. (241) 195 Boldry, R.C., see Papa, $.M. (232) 247 Bhave, S.V., see Przywara, D.A. (247) 353 Bolkenius, F.N., see Lukovic, L. (233) 63 Bianchi, C., see Tanganelli, S. (230) 159 Bolwig, T.G., see Glenthgj, B. (236) 401 Bianchi, G., Barone, D., Lanzarotti, E., Tettamanti, R., Porta, R., Bolwig, T.G., see Glenthgj, B. (242) 283 Moltrasio, D., Cedro, A., Salvetti, L., Mantovani, M. and Prino, Bomzon, A., see Pauletzki, J.G. (232) 263 G. Bon, C., see Tesson, F. (248) 27 Defibrotide, a single-stranded polydeoxyribonucleotide acting as Bon, C., see Tesson, F. (248) 351 an adenosine receptor agonist (238) 327 Bonadonna, A.M., see Levy, A.D. (241) 275 Bianchi, R., Zhu, X., Fiori, M.G. and Eichberg, J. Bonanno, G., see Lanza, M. (237) 191 Effect of gangliosides on diacylglycerol content and molecular Bond, A., see Boot, J.R. (231) 83 species in nerve from diabetic rats (239) 55 Bondiolotti, G.P., see Cattaneo, L. (241) 245 Bianchin, M., see Jerusalinsky, D. (240) 103 Bonini, I., see Sacchetti, G. (236) 171 Bidlack, J.M., see Jiang, Q. (230) 129 Boniotti, A., see Mapp, C.E. (248) 67 Bidlack, J.M., see Jiang, Q. (240) 201 Boniotti, A., see Mapp, C.E. (248) 277 Bidzseranova, A., Varga, J. and Telegdy, G. Bonnafous, C., Martinez, J., Fargeas, M.-J. and Buéno, L. The effects of brain natriuretic peptide-32 on electroconvulsive Clonazepam-induced intestinal motor disturbances are linked to shock-induced amnesia in rats. The role of neurotransmitters central nervous system release of cholecystokinin in rats (237) 237 (232) 305 Bonnet, J.-J., see Billaud, G. (247) 333 Biegon, A., see Jagust, W.J. (242) 189 Bonnet, J.-J., see Vaugeois, J.-M. (230) 195 Bigg, D.C.H., see Sleight, A.J. (238) 407 Bonnot-Lours, S., see Tavitian, B. (236) 229 Biggio, G., see Imperato, A. (238) 135 Boot, J.R., Bond, A., Thomas, K.H., O’Brien, A., Gilmore, J. and Bill, D.J., see Fletcher, A. (237) 283 Todd, A. Bill, S.J., see Fletcher, A. (237) 283 The pharmacology of LY290324 in the guinea-pig: an orally Billaud, G., Costentin, J. and Bonnet, J.-J. active, potent and selective cysteinyl leukotriene receptor antago- Specific binding of [7H]GBR 12783 to the dopamine neuronal nist (231) 83 carrier included in polarized membranes (247) 333 Borelli, G.P., see Tubaro, E. (248) 175